(Q30416689)

21 June 2017

title

Global tuberculosis control: lessons learnt and future prospects (English)

1 reference

21 June 2017

0 references

Philippe Glaziou

2

0 references

Mario Raviglione

object named as

Mario Raviglione

series ordinal

6

0 references

Knut Lönnroth

series ordinal

4

object named as

Knut Lönnroth

1 reference

21 June 2017

3

Mukund Uplekar

1 reference

21 June 2017

1

Christian Lienhardt

1 reference

21 June 2017

Haileyesus Getahun

5

1 reference

21 June 2017

language of work or name

English

0 references

publication date

14 May 2012

1 reference

Nature Reviews Microbiology

21 June 2017

published in

1 reference

21 June 2017

volume

10

1 reference

21 June 2017

issue

6

1 reference

21 June 2017

page(s)

407-416

1 reference

From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Chemotherapy of pulmonary tuberculosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Evolution of WHO policies for tuberculosis control, 1948-2001.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Health sector reform: making health development sustainable

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Tuberculosis: commentary on a reemergent killer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

The global tuberculosis situation and the new control strategy of the World Health Organization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

The problem of self-administration of drugs; with particular reference to pulmonary tuberculosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Directly observed treatment of tuberculosis. We can't afford not to try it

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Assessment of worldwide tuberculosis control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

The effect of tuberculosis control in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Directly observed therapy and treatment adherence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Directly Observed Treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Disseminated tuberculosis and the acquired immunodeficiency syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Association between HTLV-III/LAV infection and tuberculosis in Zaire

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

HIV infection-associated tuberculosis: the epidemiology and the response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

The HIV-associated tuberculosis epidemic--when will we act?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

The emergence of drug-resistant tuberculosis in New York City

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

PUBLIC HEALTH: Responding to Market Failures in Tuberculosis Control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Increasing transparency in partnerships for health--introducing the Green Light Committee

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

A global health fund: a leap of faith?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

The Global Fund: managing great expectations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

From HIV to tuberculosis and back again: a tale of activism in 2 pandemics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

International standards for tuberculosis care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Tackling poverty in tuberculosis control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

WHO's new Stop TB Strategy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Global tuberculosis drug development pipeline: the need and the reality.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Rapid molecular detection of tuberculosis and rifampin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

New vaccines for tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Tuberculosis control and elimination 2010–50: cure, care, and social development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Health-system strengthening and tuberculosis control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

What research is needed to stop TB? Introducing the TB Research Movement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Alcohol use as a risk factor for tuberculosis - a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Drivers of tuberculosis epidemics: the role of risk factors and social determinants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Transforming the global tuberculosis response through effective engagement of civil society organizations: the role of the World Health Organization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2797

Public-private mix for DOTS implementation: what makes it work?

31 March 2020

1 reference

12 December 2020

Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.

1 reference

12 December 2020

Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis

1 reference

12 December 2020

From the Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991

1 reference

12 December 2020

Tuberculosis and HIV infection in sub-Saharan Africa

1 reference

12 December 2020

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

1 reference

12 December 2020

Science and social justice: the lessons of HIV/AIDS activism in the struggle to eradicate tuberculosis

1 reference

12 December 2020

Global Partnership to Stop TB: a model of an effective public health partnership.

1 reference

12 December 2020

How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.

1 reference

12 December 2020

Recent advances in epidemiological research in tuberculosis

1 reference

12 December 2020

New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes

1 reference

12 December 2020

Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries

1 reference

12 December 2020

WHO EXPERT COMMITTEE ON TUBERCULOSIS. EIGHTH REPORT

1 reference

12 December 2020

Low access to a highly effective therapy: a challenge for international tuberculosis control.

1 reference

12 December 2020

The Global Plan to Stop TB, 2006-2015. actions for life: towards a world free of tuberculosis

1 reference

12 December 2020

Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project.

1 reference

12 December 2020

Report on the meeting of the Second Ad Hoc Committee on the TB epidemic: recommendations to Stop TB Partners, Montreux, Switzerland, 18-19 September 2003

1 reference

12 December 2020

The Global TB Drug Facility: innovative global procurement

1 reference

12 December 2020

Health sector reform: scourge or salvation for TB control in developing countries?

1 reference

12 December 2020

Principles of IUATLD collaborative tuberculosis progammes

1 reference

12 December 2020

Tuberculosis in developing countries: burden, intervention and cost

1 reference

12 December 2020

TUBERCULOSIS IN TROPICAL AFRICA. AN EPIDEMIOLOGICAL STUDY

1 reference

12 December 2020

A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO2797

1 reference

Dimensions Publication ID

21 June 2017

1030142229

0 references

1 reference